|
SMARCC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.952900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.132330E-02 |
| Normal-vs-Stage2 |
2.607800E-01 |
| Normal-vs-Stage3 |
1.782560E-01 |
| Normal-vs-Stage4 |
3.719000E-01 |
| Stage1-vs-Stage2 |
8.401200E-01 |
| Stage1-vs-Stage3 |
7.494800E-01 |
| Stage1-vs-Stage4 |
2.639700E-02 |
| Stage2-vs-Stage3 |
9.476200E-01 |
| Stage2-vs-Stage4 |
2.018400E-01 |
| Stage3-vs-Stage4 |
1.599840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.779140E-03 |
| Normal-vs-AfricanAmerican |
2.641700E-02 |
| Normal-vs-Asian |
9.276000E-01 |
| Caucasian-vs-AfricanAmerican |
8.371800E-01 |
| Caucasian-vs-Asian |
3.843800E-01 |
| AfricanAmerican-vs-Asian |
3.669600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.643100E-03 |
| Normal-vs-Female |
1.921100E-03 |
| Male-vs-Female |
2.958400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.872630E-01 |
| Normal-vs-Extreme_Weight |
1.581410E-01 |
| Normal-vs-Obese |
5.777300E-03 |
| Normal-vs-Extreme_Obese |
5.932800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.609800E-01 |
| Normal_Weight-vs-Obese |
2.888000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.030400E-01 |
| Extreme_Weight-vs-Obese |
2.333600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.761800E-01 |
| Obese-vs-Extreme_Obese |
9.748000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.70920000000163E-05 |
| Normal-vs-Age(41-60Yrs) |
1.445880E-04 |
| Normal-vs-Age(61-80Yrs) |
7.242500E-02 |
| Normal-vs-Age(81-100Yrs) |
9.723000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.276000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.117800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.168300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.704400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.968300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.603000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.06339999997418E-06 |
| Normal-VS-Type2 PRCC |
2.323000E-01 |
| Normal-VS-KIRP CIMP |
2.106000E-01 |
| Normal-VS-Unclassified PRCC |
1.838170E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.17270000271819E-08 |
| Type1 PRCC-VS-KIRP CIMP |
7.828500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.810800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.573610E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.803600E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
3.141600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.813200E-01 |
| Normal-vs-N1 |
1.571790E-01 |
| Normal-vs-N2 |
1.527930E-02 |
| N0-vs-N1 |
2.754000E-01 |
| N0-vs-N2 |
2.140600E-01 |
| N1-vs-N2 |
7.408800E-01 |
|
|
